1892例肝衰竭患者并发症及死亡原因分析

doi:10.3969/j.issn.1672-5069.2014.02.005

摘要/Abstract

摘要： 目的探讨肝衰竭的并发症和死亡原因及两者之间的关系。方法回顾性总结1892例肝衰竭患者的临床资料，对年龄、性别、病因、并发症和临床转归等方面进行比较分析。结果 1892例患者中，男性1206例（63.74%），女性686例（36.26%），平均年龄（48.9±11.3）岁；肝衰竭病因主要为乙型肝炎病毒感染（1319例，69.7%）、HEV感染102例（5.4%）、药物（102例，5.4%）、酒精（89例，4.7%）和不明原因（107例，5.7%）；1543例（81.6%）患者发生了肝衰竭相关的并发症，包括感染、出血、肝性脑病、肝肾综合征和脑水肿，发生率分别为69.82%、30.97%、23.04%、16.97%和2.59%；急性肝衰竭患者在肝性脑病、肝肾综合征和脑水肿的发生率分别为77.14%，45.71%和20.0%，发生率均明显高于其它几型肝衰竭（P<0.05）；发生脑水肿的49例患者死亡率为100%，发生肝肾综合征的291例患者死亡率为90.65%；1092例发生一种并发症的患者死亡率为62.09%，288例发生两种并发症的患者死亡率为78.47%，163例患者发生3种及3种以上并发症的患者死亡率高达98.16%。结论肝衰竭易发生并发症，感染是肝衰竭患者最常见的并发症，脑水肿和肝肾综合征是最严重的并发症；肝衰竭患者的死亡率随并发症增多而升高。

关键词: 肝衰竭, 并发症, 死亡原因

Abstract: Objective To investigate the complications and death causes，and their relationship，in patients with liver failure. Methods The age，gender，etiology，complication，and prognosis of the 1892 patients with liver failure were retro-prospectively analyzed. Results There were 1206（63.74%） cases of male and 686 cases（36.26%） of female included in this study，with an average age of（48.9±11.3） years；The major causes of liver failure included hepatitis B virus infection（1319，69.7%），hepatitis E virus infection（102，5.4%），drug-induced liver injury（102，5.4%），alcohol （89，4.7%）and unknown etiology（107，5.7%）；A total of 1543 patients with liver failure suffered from complications including infection，hemorrhage，hepatic encephalopathy，hepatorenal syndrome，and encephaledema，and their incidence were 69.82%，30.97%，23.04%，16.97%，and 2.59%，respectively；The incidences of hepatic encephalopathy（77.14%），hepatorenal syndrome（45.71%），and encephaledema（20.0%） were significantly higher in patients with acute liver failure than all other kinds of liver failure（P<0.05）；The mortality of patients with encephaledema was 100%，while the mortality of patients with hepatorenal syndrome was 90.65%；The mortality of 1092 patients with one complication was 62.09%，and 288 patients with two complications was 78.47%；Furthermore，the mortality of 163 patients with three or more complications was up to 98.16%. Conclusion Patients with liver failure was prone to suffering from complications，and the most common complication was infection，while the worst complications were encephaledema and hepatorenal syndrome；The mortality of patients with liver failure increases with the numbers of complications.

Key words: Liver failure, Complications, Death cause

张野，聂青和. 1892例肝衰竭患者并发症及死亡原因分析[J]. 实用肝脏病杂志, 2014, 17(2): 129-132.

Zhang Ye，Nie Qinghe.. Analysis of complications and death causes of 1892 patients with liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 129-132.

参考文献

[1] 聂青和. 重型肝炎综合治疗进展的临床教学实践及体会.实用肝脏病杂志，2006，9（2）:104-106.
[2] Poison J，Lee WM. AASLD position paper: the management of acute liver failure. Hepatology，2005，41:1179-1197.
[3] 中华医学会感染病学分会肝衰竭与人工肝学组，中华医学会肝病学分会重型肝病与人工肝学组．肝衰竭诊疗指南. 实用肝脏病杂志，2006，9:321-324.
[4] 中华医学会感染病学分会肝衰竭与人工肝学组，中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南（2012年版）. 实用肝脏病杂志，2013，16:210-216.
[5] 李梦东，聂青和. 肝衰竭的研究现状与展望. 实用肝脏病杂志，2013，16:9-11.
[6] 聂青和. 肝衰竭综合治疗进展.实用肝脏病杂志，2013，16:17-19.
[7] Bachir NM，Larson AM．Adult liver transplantation in the United States．Am J Med Sci，2012，343：462-469.
[8] Khan SA，Shah N，Williams R，et al．Acute liver failure：a review. Clin Liver Dis，2006，10：239-258.
[9] 聂青和.肝硬化慢性肝衰竭的临床治疗实践.中国实用内科杂志，2013，33:698-701.
[10] Nie QH，Yang J，Wang AH，et a1．Effects of intestinal intervention on bacterial translocation in a rat model of acute liver failure in vivo. Eur J Gastroenterol Hepato1，2010，22：1316-1322.
[11] 高禄化，聂青和. 肝衰竭继发感染临床进展. 肝脏，2013，18：61-62.
[12] Leber B，Spindelboeck W，Stadlbauer V．Infectious complications of acute and chronic liver disease． Semin Respir Crit Care Med，2012，33：80-95．
[13] Tranah TH，Vijay GK，Ryan JM，et al. Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis， 2013，28:1-5.
[14] Detry O，De Roover A，Honore P，et al. Brain edema and intracranial hypertension in fulminant hepatic failure：Pathophysiology and management. World J Gastroenterol，2006，46:7405-7412.
[15] Thayapararajah SW，Gulka I，Al-Amri A，et al. Acute fulminant hepatic failure，encephalopathy and early CT changes. Can J Neurol Sci，2013，40:553-557.
[16] Wong F. Recent advances in our understanding of hepatorenal syndrome. Nat Rev Gastroenterol Hepatol，2012，9:382-391.
[17] 聂青和. 肝肾综合征诊断及治疗进展.实用临床医药杂志，2007，11（3）：10-12.
[18] Angeli P，Merkel C．Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol，2008，48：S93-S103．
[19] Arroyo V，Fernandez J，Gines P．Pathogenesis and treatment of hepatorenal syndrome．Semin Liver Dis，2008，28：81-95．
[20] Canabal J M，Kramer DJ．Management of sepsis in patients with liver failure．Cur Opin Crit Care，2008，14：189-97.
[21] 聂青和. 肝衰竭实验室检测临床价值及新指标评价.临床肝胆病杂志，2013，29：666-669.